Skip to content

CYPH CYPH Deferred contract costs

Deferred contract costs at other companies

CTO
Citius Oncology, Inc.CTOR

Other financials

Income statement

See full
Revenue$375.0K
Operating income-$4.8M+69.7%
Net income-$77.2M-400%
EPS (diluted)-$0.46-24.3%

Balance sheet

See full
Cash & equivalents$6.7M-79.6%
Total debt$38.0K-75.3%
Total equity$84.4M+305%
Total assets$87.4M+151%

Cash flow

See full
Operating cash flow-$3.4M+76.3%

Valuation

See full
Market cap$65.19M-58.2%
Enterprise value$58.54M
P/S43.5×

Profitability

See full
Operating margin-2,761.7%
Net margin-2,705.8%

Returns & leverage

See full
Return on equity-108.2%-34.4pp
Debt / equity0.0×
Current ratio27.3×+24.9×

Where this comes from

Reported directly by CYPH in its filing.

Tagged under the XBRL concept us-gaap:DeferredCosts.

The official record: CYPH’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CYPH's deferred contract costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CYPH's deferred contract costs?
CYPH (CYPH) reported deferred contract costs of $385K in Q1 2026.
What does deferred contract costs mean?
These are incremental costs incurred to obtain or fulfill a contract that are capitalized and amortized over the expected period of benefit, extending beyond one year. This metric provides insight into the company's long-term customer acquisition efficiency and the timing of expense recognition relative to revenue generation. It is essential for understanding the underlying profitability of long-term service or subscription agreements.